48 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

Page of 1

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1BCalcium channel, voltage-dependent, N type, alpha 1B subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
CACNA1CCalcium channel, voltage-dependent, L type, alpha 1C subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1DCalcium channel, voltage-dependent, L type, alpha 1D subunitCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1SCalcium channel, voltage-dependent, L type, alpha 1S subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
CATSPER4Cation channel, sperm associated 4Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
CNGA2Cyclic nucleotide gated channel alpha 2Predicted membrane proteins
Voltage-gated ion channels
Not detected
GALNT8Polypeptide N-acetylgalactosaminyltransferase 8Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Voltage-gated ion channels
Tissue enhanced
HCN1Hyperpolarization activated cyclic nucleotide-gated potassium channel 1Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA3Potassium voltage-gated channel, shaker-related subfamily, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium voltage-gated channel, shaker-related subfamily, member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA5Potassium voltage-gated channel, shaker-related subfamily, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNA6Potassium voltage-gated channel, shaker-related subfamily, member 6FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNB1Potassium voltage-gated channel, Shab-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC1Potassium voltage-gated channel, Shaw-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNF1Potassium voltage-gated channel, subfamily F, member 1Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNG1Potassium voltage-gated channel, subfamily G, member 1Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNG4Potassium voltage-gated channel, subfamily G, member 4Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNH1Potassium voltage-gated channel, subfamily H (eag-related), member 1Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNH2Potassium voltage-gated channel, subfamily H (eag-related), member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ1Potassium inwardly-rectifying channel, subfamily J, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ11Potassium inwardly-rectifying channel, subfamily J, member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNJ12Potassium inwardly-rectifying channel, subfamily J, member 12FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNJ15Potassium inwardly-rectifying channel, subfamily J, member 15Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNJ16Potassium inwardly-rectifying channel, subfamily J, member 16Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ3Potassium inwardly-rectifying channel, subfamily J, member 3Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ5Potassium inwardly-rectifying channel, subfamily J, member 5Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNK1Potassium channel, subfamily K, member 1Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCNK5Potassium channel, subfamily K, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK6Potassium channel, subfamily K, member 6Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNMA1Potassium large conductance calcium-activated channel, subfamily M, alpha member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNN4Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel, KQT-like subfamily, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel, KQT-like subfamily, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNQ5Potassium voltage-gated channel, KQT-like subfamily, member 5Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
MCOLN1Mucolipin 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Expressed in all
MCOLN3Mucolipin 3Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
PKD2Polycystic kidney disease 2 (autosomal dominant)Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Expressed in all
PKD2L2Polycystic kidney disease 2-like 2Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
SCN11ASodium channel, voltage-gated, type XI, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
SCN2ASodium channel, voltage-gated, type II, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
TPCN2Two pore segment channel 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Expressed in all
TRPC1Transient receptor potential cation channel, subfamily C, member 1Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
TRPC6Transient receptor potential cation channel, subfamily C, member 6Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPM4Transient receptor potential cation channel, subfamily M, member 4Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
TRPM5Transient receptor potential cation channel, subfamily M, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
TRPV4Transient receptor potential cation channel, subfamily V, member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
TRPV6Transient receptor potential cation channel, subfamily V, member 6Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced

Page of 1